A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer

A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer

Yeon Joo Kim, Jin-hong Park, In-Ha Yun, Young Seok KimDepartment of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of KoreaPurpose: To compare the acute intestinal toxicity of whole pelvic (WP) and small field (SF) intensity-modulated radiotherapy...

Full description

Bibliographic Details
Main Authors:	Kim YJ, Park JH, Yun IH, Kim YS
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-03-01
Series:	OncoTargets and Therapy
Subjects:	Prostate cancer intensity modulated radiotherapy intestinal toxicity citrulline
Online Access:	https://www.dovepress.com/a-prospective-comparison-of-acute-intestinal-toxicity-following-whole--peer-reviewed-article-OTT

Similar Items

Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
by: Rakesh Kapoor, et al.
Published: (2016-01-01)

Acute and late toxicity in radical radiotherapy of prostate cancer
by: Josifovski Tatjana, et al.
Published: (2009-01-01)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
by: Hun Jung Kim, et al.
Published: (2015-12-01)

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
by: Williams Scott, et al.
Published: (2011-10-01)

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
by: Eckert Franziska, et al.
Published: (2013-01-01)

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
by: Xingsi Peng, et al.
Published: (2019-10-01)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High Risk Localized Prostate Cancer
by: Yu-Wei eLin, et al.
Published: (2014-10-01)

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
by: Lucas C. Mendez, et al.
Published: (2020-10-01)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
by: Yeon Joo Kim, et al.
Published: (2020-10-01)

Intensity modulated radiotherapy in postoperative treatment of cervical cancer
by: Marjanović Dragoslava, et al.
Published: (2019-01-01)

Intravenous citrulline generation test to assess intestinal function in intensive care unit patients
by: Peters JH, et al.
Published: (2017-04-01)

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia
by: Mélanie Guilhen, et al.
Published: (2018-10-01)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
by: Yeon Joo Kim, et al.
Published: (2018-04-01)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
by: Shih-Chang Wang, et al.
Published: (2020-05-01)

Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
by: Bin S. Teh, et al.
Published: (2018-04-01)

Gaps Between Evidence and Practice in Post-operative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life
by: Hamid eRaziee, et al.
Published: (2016-03-01)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
by: Hideya Yamazaki, et al.
Published: (2020-11-01)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
by: Keisuke Tsuchida, et al.
Published: (2020-09-01)

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan
by: Takeda Ken, et al.
Published: (2012-07-01)

Intensity-Modulated Radiotherapy in the Treatment of Pancreatic Adenocarcinoma – A Review
by: Luciana Caravatta, et al.
Published: (2013-10-01)

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
by: Tao HM, et al.
Published: (2016-03-01)

Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial
by: Van Nguyen Thu, et al.
Published: (2011-09-01)

Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow
by: Lucia Clara Orlandini, et al.
Published: (2017-04-01)

Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy
by: Chien-Chih Chen, et al.
Published: (2014-12-01)

Comparing bowel and urinary domains of patient‐reported quality of life at the end of and 3 months post radiotherapy between intensity‐modulated radiotherapy and proton beam therapy for clinically localized prostate cancer
by: Miao Bai, et al.
Published: (2020-11-01)

Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
by: Krause Sonja, et al.
Published: (2012-10-01)

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
by: Matthias Felix Haefner, et al.
Published: (2017-08-01)

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors
by: Milly BUWENGE, et al.
Published: (2020-02-01)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
by: Wilma D. Heemsbergen, et al.
Published: (2020-04-01)

Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
by: Mark E. Hwang, et al.
Published: (2019-08-01)

Prognostic factors for late urinary toxicity grade 2-3 after conformal radiation therapy on patients with prostate cancer
by: Ricardo A. Nakamura, et al.
Published: (2007-10-01)

Pelvic bone anatomy vs implanted gold seed marker registration for image-guided intensity modulated radiotherapy for prostate carcinoma: Comparative analysis of inter-fraction motion and toxicities
by: Madhup Rastogi, et al.
Published: (2017-12-01)

Pelvic symptoms after radiotherapy in prostate cancer: a cross-sectional study
by: Aline Moreira Ribeiro, et al.

Prospective study on acute toxicities of external beam radiotherapy in the management of pelvic malignancies in Lagos University Teaching Hospital
by: Bolanle Comfort Adegboyega, et al.
Published: (2020-01-01)

Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy
by: Leila E.A. Shelley, et al.
Published: (2020-04-01)

Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?
by: Rémi Bourdais, et al.
Published: (2021-07-01)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
by: Marie-Christina Jahreiß, et al.
Published: (2020-11-01)

Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review
by: Paul Sargos, et al.
Published: (2021-06-01)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
by: Sebastian Adeberg, et al.
Published: (2019-12-01)

Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial
by: Jin Huang, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_q69i4qkvoqtaijmp3ncsq77i0o